Мировой рынок доставки лекарств – тенденции отрасли и прогноз до 2029 года

Анализ и размер рынка

В последние годы ожидается, что рынок доставки лекарств будет расширяться в течение прогнозируемого периода. По данным Всемирной организации здравоохранения (ВОЗ), ожидается, что распространенность хронических заболеваний к концу 2020 года вырастет на 57%, согласно данным Всемирной организации здравоохранения (ВОЗ). Желание систем здравоохранения больше сосредоточиться на передовых технологиях доставки лекарств быстро возросло в ответ на рост хронических заболеваний. Кроме того, все больше внимания уделяется безопасности, эффективности и удобству для пациентов. Рынок доставки лекарств увеличится в ближайшие годы из-за спроса на сложные технологии для удовлетворения растущего спроса на обычные инъекционные фармацевтические препараты для лечения хронических заболеваний.

По данным Data Bridge Market Research, рынок доставки лекарств в 2021 году оценивался в 1458,19 млн долларов США, а к 2029 году, как ожидается, достигнет 2800,61 млн долларов США, что соответствует среднегодовому темпу роста (CAGR) 8,50% в прогнозируемый период с 2022 по 2029 год. Отчет о рынке, подготовленный командой Data Bridge Market Research, включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ линейки препаратов, анализ цен и нормативно-правовую базу.

Определение рынка

Доставка лекарств обеспечивает терапевтический эффект в организме человека, доставляя лекарство в определенное целевое место. Безопасность и эффективность можно повысить, регулируя скорость, время и высвобождение лекарства в организме. Лекарства можно доставлять различными способами, включая пероральный, инъекционный, легочный, назальный и другие пути. Особенности наночастиц были изучены и использованы для разработки систем доставки лекарств, что сделало процесс распределения лекарств более эффективным и экономящим время.

Область отчета и сегментация рынка

Drug Delivery Market Dynamics

Drivers

• Rise in the prevalence of chronic diseases

The rising prevalence of chronic diseases is estimated to propel the drug delivery market's growth. Sedentary lifestyles have become commonplace as a result of rapid technological adoption. Obesity rates are rising as a result of this change in lifestyle, which is leading to a slew of chronic ailments such as diabetes and heart disease.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of drug delivery market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness and technological advancement will expand the drug delivery market. Additionally, high disposable income and increasing adoption of advanced drug administration systems will result in the expansion of drug delivery market. Along with this, rising geriatric population and rising demand for biosimilars and biologics will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the drug delivery market growth. Along with this, rising drug approvals and launch of innovative products will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the drug delivery market during the forecast period.

Restraints/Challenges

On the other hand, the increasing number of drug recalls and drug failures will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the drug delivery market. Additionally, the risk of needle stick injuries will restrain and further impede the market's growth rate during the forecast period of 2022-2029.

This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Drug Delivery Market

Over the projected period, the drug delivery market is expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations have imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world are having difficulty continuing their supply chain activities. The supply chain slowness has also hampered the drug delivery market.

Recent Development

• In March 2022, Sandoz, a Novartis division, announced the acquisition of a UK-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, which will help the company expand its respiratory medication portfolio and improve patient access to high-quality, complex therapeutics.

Global Drug Delivery Market Scope

The drug delivery market is segmented on the basis of product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Oral Drug Delivery
• Pulmonary Drug Delivery
• Injectable Drug Delivery
• Ophthalmic Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, ophthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery.

Application

• Cancer
• Diabetes
• Respiratory Diseases
• Cardiovascular Diseases
• Others

Based on application, the market is segmented into cancer, diabetes, respiratory diseases, cardiovascular diseases and others.

 End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the drug delivery market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the drug delivery market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Drug Delivery Market Regional Analysis/Insights

The Drug delivery market is analysed and market size insights and trends are provided by country, product type, application, end-users and distribution channel as referenced above.

The countries covered in the Drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the drug delivery market because of the presence of major key players and well-established healthcare infrastructure in this region. Additionally, the increase in the prevalence of chronic diseases and development of biologics and pharmaceutical drugs as well as devices will further propel the market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to the growing geriatric population and obtainability of self-administration in this region. Also, development of healthcare infrastructure will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Drug Delivery Market Share Analysis

The Drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery market.

Some of the major players operating in the drug delivery market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Израиль)
• Sanofi (Франция), Pfizer Inc. (США)
• GlaxoSmithKline plc (Великобритания)
• Новартис АГ (Швейцария)
• Sun Pharmaceutical Industries Ltd. (Индия)
• Dr. Reddy's Laboratories Ltd. (Индия)
• Bausch Health Companies Inc. (Канада)
• АстраЗенека (Великобритания)
• Johnson & Johnson Private Limited (США)
• Merck & Co., Inc. (США)
• Кадила Фармасьютикалс. (Индия)
• 3M (США)
• Bayer AG (Германия)
• Астеллас Фарма Инк. (Япония)
• AbbVie Inc. (США)
• Takeda Pharmaceutical Company Limited (Япония) 

SKU-52812